The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial …
Objectives: We attempted to compare the effect of an angiotensin-converting enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic events. Background …
inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic events. Background …
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design
MA Pfeffer, J McMurray, A Leizorovicz, AP Maggioni… - American heart …, 2000 - Elsevier
Background Survivors of acute myocardial infarction (MI) complicated by heart failure and/or
resulting in left ventricular dysfunction are at heightened risk for subsequent death and …
resulting in left ventricular dysfunction are at heightened risk for subsequent death and …
Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers
MA Pfeffer - American heart journal, 2000 - Elsevier
Treatment of acute myocardial infarction (MI) has been advanced considerably in the past
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
N Bissessor, H White - Vascular health and risk management, 2007 - Taylor & Francis
The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease
J Kondo, T Sone, H Tsuboi, H Mukawa, I Morishima… - American heart …, 2003 - Elsevier
OBJECTIVES: The purpose of this study was to investigate the effects of angiotensin II
receptor blockers on the prevention of cardiovascular events in patients with coronary artery …
receptor blockers on the prevention of cardiovascular events in patients with coronary artery …
Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds
Background A recent editorial published by Verma and Strauss, entitled 'Angiotensin
receptor blockers and myocardial infarction', examined, through a partial analysis of …
receptor blockers and myocardial infarction', examined, through a partial analysis of …
The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death
MH Strauss, AS Hall - Progress in Cardiovascular Diseases, 2016 - Elsevier
The renin angiotensin aldosterone system (RAAS) plays a central role in the
pathophysiology of hypertension and vascular disease. Angiotensin converting enzyme …
pathophysiology of hypertension and vascular disease. Angiotensin converting enzyme …
Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
K Dickstein, J Kjekshus… - The American journal of …, 1999 - Elsevier
Patients with acute myocardial infarction and evidence of heart failure or left ventricular
dysfunction during the acute phase have an excessive mortality risk. Therapy with …
dysfunction during the acute phase have an excessive mortality risk. Therapy with …
Angiotensin receptor blockers and risk of myocardial infarction: systematic review
MA McDonald, SH Simpson, JA Ezekowitz, G Gyenes… - bmj, 2005 - bmj.com
Objective To evaluate the effect of angiotensin receptor blockers on the risk of myocardial
infarction in patients at risk for cardiovascular events. Design Systematic review of controlled …
infarction in patients at risk for cardiovascular events. Design Systematic review of controlled …
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials
Objective To evaluate the effects of treatments based on angiotensin II receptor blockers
(ARBs) on the risk of myocardial infarction (MI), cardiovascular and all-cause death, as …
(ARBs) on the risk of myocardial infarction (MI), cardiovascular and all-cause death, as …